Ofirmev
CP-001-12
Approved small_molecule completed
Quick answer
Ofirmev for Pain is a Approved program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CUMBERLAND PHARMACEUTICALS INC
- Indication
- Pain
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed